Patterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients

被引:31
作者
Kim, Hyung Won [1 ]
Lee, Hak Min [1 ]
Hwang, Seung Hyun [1 ]
Alm, Sung Gwe [1 ]
Lee, Kyung-A [2 ]
Jeong, Joon [1 ]
机构
[1] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Surg, Seoul 135720, South Korea
[2] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Lab Med, Seoul 135720, South Korea
关键词
Breast neoplasms; Mutation; p53; Genes; LIQUID-CHROMATOGRAPHY; MOLECULAR PORTRAITS; TP53; GENE; PROGNOSIS; TUMORS; PHENOTYPE; SURVIVAL; THERAPY;
D O I
10.4048/jbc.2014.17.1.1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The p53 gene is one of the most frequently mutated genes in breast cancer. We investigated the patterns and biologic features of p53 gene mutation and evaluated their clinical significance in Korean breast cancer patients. Methods: Patients who underwent p53 gene sequencing were included. Mutational analysis of exon 5 to exon 9 of the p53 gene was carried out using polymerase chain reaction-denaturing high performance liquid chromatography and direct sequencing. Results: A total of 497 patients were eligible for the present study and p53 gene mutations were detected in 71 cases (14.3%). Mutation of p53 was significantly associated with histologic grading (p<0.001), estrogen receptor and progesterone receptor status (p<0.001), HER2 status (p<0.001), Ki-67 (p=0.028), and tumor size (p=0.004). The most frequent location of p53 mutations was exon 7 and missense mutation was the most common type of mutation. Compared with patients without mutation, there was a statistically significant difference in relapse-free survival of patients with p53 gene mutation and missense mutation (p=0.020, p=0.006, respectively). Only p53 missense mutation was an independent prognostic factor for relapse-free survival in multivariate analysis, with an adjusted hazard ratio of 2.29 (95% confidence interval, 1.08-4.89, p=0.031). Conclusion: Mutation of the p53 gene was associated with more aggressive clinicopathologic characteristics and p53 missense mutation was an independent negative prognostic factor in Korean breast cancer patients.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 23 条
  • [1] Alsner J, 2000, CLIN CANCER RES, V6, P3923
  • [2] Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
    Berns, EMJJ
    van Staveren, IL
    Look, MP
    Smid, M
    Klijn, JGM
    Foekens, JA
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (07) : 1130 - 1136
  • [3] Berns EMJJ, 2000, CANCER RES, V60, P2155
  • [4] TP53 and breast cancer
    Borresen-Dale, AL
    [J]. HUMAN MUTATION, 2003, 21 (03) : 292 - 300
  • [5] The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer
    Bull, SB
    Ozcelik, H
    Pinnaduwage, D
    Blackstein, ME
    Sutherland, DAJ
    Pritchard, KI
    Tzontcheva, AT
    Sidlofsky, S
    Hanna, WM
    Qizilbash, AH
    Tweeddale, ME
    Fine, S
    McCready, DR
    Andrulis, IL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) : 86 - 96
  • [6] The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
    Curtis, Christina
    Shah, Sohrab P.
    Chin, Suet-Feung
    Turashvili, Gulisa
    Rueda, Oscar M.
    Dunning, Mark J.
    Speed, Doug
    Lynch, Andy G.
    Samarajiwa, Shamith
    Yuan, Yinyin
    Graef, Stefan
    Ha, Gavin
    Haffari, Gholamreza
    Bashashati, Ali
    Russell, Roslin
    McKinney, Steven
    Langerod, Anita
    Green, Andrew
    Provenzano, Elena
    Wishart, Gordon
    Pinder, Sarah
    Watson, Peter
    Markowetz, Florian
    Murphy, Leigh
    Ellis, Ian
    Purushotham, Arnie
    Borresen-Dale, Anne-Lise
    Brenton, James D.
    Tavare, Simon
    Caldas, Carlos
    Aparicio, Samuel
    [J]. NATURE, 2012, 486 (7403) : 346 - 352
  • [7] Edge S.B., 2010, AJCC cancer staging manual, V649
  • [8] Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
    Goldhirsch, A.
    Wood, W. C.
    Coates, A. S.
    Gelber, R. D.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (08) : 1736 - 1747
  • [9] Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma
    Grann, VR
    Troxel, AB
    Zojwalla, NJ
    Jacobson, JS
    Hershman, D
    Neugut, AI
    [J]. CANCER, 2005, 103 (11) : 2241 - 2251
  • [10] Impact of triple negative phenotype on breast cancer prognosis
    Kaplan, Henry G.
    Malmgren, Judith A.
    [J]. BREAST JOURNAL, 2008, 14 (05) : 456 - 463